Side-by-side financials for CHRS and ARGX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CHRS | ARGX |
|---|---|---|
| Market cap | - | $55.29 B |
| US-listed rank | - | #303 |
| Revenue (latest FY) | $42.17M | - |
| Net income (latest FY) | $168.02M | - |
| Net margin | 398.4% | - |
| SEC filings | 898 | 272 |
Full pages: Coherus BioSciences, Inc. and ARGENX SE, or browse the full rankings.